Vaddi Krishna 4
4 · Prelude Therapeutics Inc · Filed Feb 17, 2022
Insider Transaction Report
Form 4
Vaddi Krishna
DirectorCEO
Transactions
- Award
Employee Stock Option (right to buy)
2022-02-15+327,900→ 327,900 totalExercise: $10.58Exp: 2032-02-14→ Common Stock (327,900 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the total shares on February 15, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.